Estrogen receptors’ neuroprotective effect against glutamate-induced neurotoxicity

Neurological Sciences

Volumn 35, Issue 11, 2014, Pages 1657-1662

  Lan, Yu Long ^a   Zhao, Jie ^a,b   Li, Shao ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Liaoning Engineering Technology Centre of Target based Nature Products for Prevention and Treatment of Ageing related Neurodegeneration   (China)

Author keywords

Alzheimer s disease; Estrogen receptors; Glutamate; Neuroprotection; Neurotoxicity

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TAMOXIFEN;

ARTICLE; DEGENERATIVE DISEASE; DRUG MECHANISM; EXCITOTOXICITY; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; SECOND MESSENGER; ANIMAL; BRAIN; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; GLUTAMIC ACID; HUMANS; NEURODEGENERATIVE DISEASES; RECEPTORS, ESTROGEN;

EID: 84919919129     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1937-8     Document Type: Article

References (45)

1. Gazulla J, Cavero-Nagore M (2006) Glutamate and Alzheimer’s disease. Rev Neurol 42:427–432
2. Crescenzi R, DeBrosse C, Nanga RP et al (2014) In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy. Neuroimage. [pii]: S1053-8119(14)00544-8
3. Burbaeva GS, Boksha IS, Tereshkina EB et al (2014) A role of glutamate decarboxylase in Alzheimer’s disease. Zh Nevrol Psikhiatr Im S S Korsakova 114(4):68–72
4. Ribeiro FM, Devries RA, Hamilton A et al (2014) Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington’s disease. Hum Mol Genet 23(8):2030–2042
5. Rettberg JR, Yao J, Brinton RD (2014) Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 35(1):8–30
6. 2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res 1172:48–59
7. Kajta M, Domin H, Grynkiewicz G et al (2007) Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3beta intracellular signaling pathway. Neuroscience 145(2):592–604
8. Gingerich S, Kim GL, Chalmers JA et al (2010) Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models. Neuroscience 170(1):54–66
9. 2+ entry and protein kinase Cot in rat cerebral cortex nerve terminals. Neurochem Int 60(2):105–114
10. Millan C, Torres M, Sanchez-Prieto J (2003) Co-activation of PKA and PKC in cerebrocortical nerve terminals synergistically facilitates glutamate release. J Neurochem 87(5):1101–1111
11. 2+ entry in rat cerebrocortical nerve terminals (synaptosomes). J Pharmacol Exp Ther 309(3):951–958
12. Pittaluga A, Feligioni M, Longordo F et al (2005) Somatostatin induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, proteinkinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. J Pharmacol Exp Ther 313(1):242–249
13. Yang TT, Wang SJ (2008) Facilitatory effect of glutamate exocytosis from rat cerebrocortical nerve terminals by alpha-tocopherol, a major vitamin E component. Neurochem Int 52(6):979–989
14. 2+ entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism. Neurochem Int 57(2):168–176
15. Gursoy E, Cardounel A, Al-khlaiwi T et al (2002) Tamoxifen protects clonal mouse hippocampal (HT-22) cells against neurotoxins-induced cell death. Neurochem Int 40(5):405–412
16. Lee ES, Yin Z, Milatovic D et al (2009) Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol Sci 110(1):156–167
17. McMullan SM, Phanavanh B, Li GG et al (2012) Metabotropic glutamate receptors inhibit microglial glutamate release. ASN Neuro 4(5) (e00094)
18. Graeber MB, Li W, Rodriguez ML (2011) Role of microglia in CNS inflammation. FEBS Lett 585:3798–3805
19. Kelley KW, Dantzer R (2011) Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav Immun Suppl 1:S13–S20
20. Andrew M, Fukuda Jerome Badaut (2012) Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation 9:279
21. Lee E, Sidoryk-Wegrzynowicz M, Wang N et al (2012) GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J Bio Chem 287(32):26817–26828
22. Lee E, Sidoryk-Wegrzynowicz M, Yin Z et al (2012) Transforming growth factor-alpha mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia 60(7):1024–1036
23. Kiss J, Csaba Z, Csaki A et al (2013) Demonstration of estrogen receptor alpha protein in glutamatergic (vesicular glutamate transporter 2 immunoreactive) neurons of the female rat hypothalamus and amygdala using double-label immunocytochemistry. Exp Brain Res 226(4):595–602
24. Cimarosti H, O’Shea RD, Jones NM et al (2006) The effects of estradiol on estrogen receptor and glutamate transporter expression in organotypic hippocampal cultures exposed to oxygen-glucose deprivation. Neurochem Res 31(4):483–490
25. Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7(4):494–506
26. Lee ES, Sidoryk M, Jiang H (2009) Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J Neurochem 110(2):530–544
27. Pawlak J, Brito V, Kuppers E et al (2005) Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res 138(1):1–7
28. Kim K, Lee SG, Kegelman TP et al (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226(10):2484–2493
29. Lipatova O, Byrd D, Green JT et al (2014) Effects of continuous vs. cycling estrogen replacement on the acquisition, retention and expression of place- and response-learning in the open-field tower maze. Neurobiol Learn Mem 114C:81–89
30. Szego EM, Barabas K, Balog J et al (2006) Estrogen induces estrogen receptor alpha-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo. J Neurosci 26(15):4104–4110
31. Mermelstein PG (2009) Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors. J Neuroendocrinol 21(4):257–262
32. Grove-Strawser D, Boulware MI, Mermelstein PG (2010) Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience 170(4):1045–1055
33. Boulware MI, Weick JP, Becklund BR et al (2005) Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 25(20):5066–5078
34. Boulware MI, Mermelstein PG (2009) Membrane estrogen receptors activate metabotropic glutamate receptors to influence nervous system physiology. Steroids 74(7):608–613
35. Spampinato SF, Molinaro G, Merlo S et al (2012) Estrogen receptors and type 1 metabotropic glutamate receptors are interdependent in protecting cortical neurons against beta-amyloid toxicity. Mol Pharmacol 81(1):12–20
36. Kuo J, Hariri OR, Bondar G et al (2009) Membrane estrogen receptor-alpha interacts with metabotropic glutamate receptor type 1a to mobilize intracellular calcium in hypothalamic astrocytes. Endocrinology 150(3):1369–1376
37. Chaban V, Li J, McDonald JS et al (2011) Estradiol attenuates the adenosine triphosphate-induced increase of intracellular calcium through group II metabotropic glutamate receptors in rat dorsal root ganglion neurons. J Neurosci Res 89(11):1707–1710
38. Al-Sweidi S, Morissette M, Di Paolo T (2012) Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. J Neuroendocrinol 24(11):1375–1385
39. Traynelis SF, Wollmuth LP, McBain CJ et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405–496
40. Bryant DN, Dorsa DM (2010) Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity. Neuroscience 170(4):1261–1269
41. Aguirre C, Jayaraman A, Pike C et al (2010) Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta. J Neurochem 115(5):1277–1287
42. Carswell HV, Macrae IM, Gallagher L et al (2004) Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 287(4):H1501–H1504
43. Zhao L, Wu TW (1010) Brinton RD (2004) Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 1–2:22–34
44. Gingerich S, Kim GL, Chalmers JA et al (2010) Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models. Neuroscience 170(1):54–66
45. Liu N, Shang J, Tian F et al (2011) In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice. Brain Res 1397:66–75